S.Africa seals record deal for low-cost ARVs: minister

South Africa, home to the world's largest population of people living with HIV, said Thursday it had secured a deal to buy a key anti-retroviral (ARV) drug at the lowest price ever.

The country is the world's largest consumer of the life-saving drugs, at 21 percent of the world market.

Aaron Motsoaledi announced the country had used this massive market share to negotiate a record-low price on a three-in-one, fixed-dose .

The once-a-day tablet will cost patients 89.37 rand a month ($10, eight euros), the minister said.

"This is now the world's lowest price for this product," he said.

"In pursuit of and using innovative methods we have been able to (achieve) a massive saving."

Motsoaledi said the government had awarded a two-year, 5.9-billion-rand ($671-million, 517-million-euro) tender to three for the drug, down from an original cost of 8.1 billion rand.

Aspen Pharmacare, Cipla Medpro and Mylan pharmaceuticals are the three companies that won the tender.

The government plans to expand the treatment to reach 2.5 million people in the next two years. Patients have been taking three pills a day, but the new regimen reduces them to one and the combination has fewer side effects.

South Africa once refused to roll out ARVs under former president Thabo Mbeki, whom activists have condemned as an "AIDS denialist". But the country now has the largest anti-retroviral (ARV) programme in the world, serving 1.7 million of its 5.6 million HIV-positive people.

Demographers reported recently that life expectancy in South Africa had shot up by six years to 60 over the past few years thanks to ARV treatment.

The country has one of the world's highest , at 17.8 percent of 15- to 49-year-olds.

Doctors Without Borders (MSF) praised the deal, saying the government had used its negotiating power to buy the fixed-dose combinations at "extremely competitive prices".

Patients "now finally have access to simpler and improved treatment options—which significantly cuts down their daily pill burden from three to five pills down to just one," said Gilles Van Cutsem, the aid group's medical coordinator in South Africa.

add to favorites email to friend print save as pdf

Related Stories

S. African to double HIV patient treatment

Dec 14, 2010

(AP) -- South Africa's health minister says he has brought down the cost of HIV drugs by 53 percent, enabling the government to treat twice as many patients in the next two years.

South Africa unveils plan to halve HIV infections

Dec 01, 2011

President Jacob Zuma on Thursday unveiled a plan to halve the number of HIV infections over the next five years, cementing South Africa's turnaround from years of deadly denialism.

Recommended for you

New study reveals why some people may be immune to HIV-1

Nov 20, 2014

Doctors have long been mystified as to why HIV-1 rapidly sickens some individuals, while in others the virus has difficulties gaining a foothold. Now, a study of genetic variation in HIV-1 and in the cells ...

Virus discovery could impact HIV drug research

Nov 20, 2014

A research team led by Portland State University (PSU) biology professor Ken Stedman has unlocked the structure of an unusual virus that lives in volcanic hot springs. The discovery could pave the way for better drugs to ...

UN warns over threat of AIDS rebound

Nov 19, 2014

South African actress Charlize Theron threw her weight Tuesday behind an urgent new UN campaign to end AIDS as a global health threat by 2030.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.